Results 171 to 180 of about 17,879 (261)
Margin-driven outcomes prevail over resection planes: multivisceral surgery matches total mesorectal excision in locally advanced rectal cancer. [PDF]
Shadmanov N +3 more
europepmc +1 more source
SNPs in SH3RF3 decrease the age of onset of Alzheimer's disease (AD). Reduced SH3RF3 blunts human microglial JNK and NFkB signaling and downstream inflammatory cytokine production, which may partially explain how SH3RF3 SNPs protect against AD. ABSTRACT Understanding how high‐risk individuals are protected from Alzheimer's disease (AD) may illuminate ...
Ronak Patel +13 more
wiley +1 more source
Integrating Business Intelligence and CRM Systems With a Machine Learning Approach for Predictive Customer Retention in E-Commerce. [PDF]
Zeinali M, Ramezani Asli L, Khalili MA.
europepmc +1 more source
What's New? Oxaliplatin serves a key role in the treatment of rectal cancer, though it is a significant cause of chemotherapy‐induced peripheral neuropathy. As total neoadjuvant therapy, in which all therapy is given before surgery, has become more common, understanding neuropathy has grown increasingly important. This study examined neuropathy and its
Georg W. Wurschi +29 more
wiley +1 more source
Centromeric retrotransposons shape chromosomal evolution beyond pericentromeric regions. [PDF]
Poretti M +5 more
europepmc +1 more source
Quantifying Protein–Glycan Interactions Using Native Mass Spectrometry
ABSTRACT Interactions between glycan‐binding proteins (GBPs) and carbohydrates (glycans) are essential to many biological processes relevant to human health and disease. For most GBPs, however, their glycan interactome—the repertoire of glycans recognized and their specificities—is poorly defined.
Duong T. Bui +4 more
wiley +1 more source
Protein quality and allergenicity assessment of chia seeds (<i>Salvia hispanica</i>): a molecular perspective on novel food safety. [PDF]
Calcinai L +5 more
europepmc +1 more source
A Knowledge Base of Designs and Statistical Methods for Adaptive Clinical Dose‐Finding Trials
ABSTRACT Adaptive clinical dose‐finding trials aim to identify an optimal drug dose for use in subsequent phase II and III trials. In adaptive dose‐finding trials, dose levels for newly included patients are informed by outcomes of patients that received the drug earlier in the trial.
Rob Kessels +8 more
wiley +1 more source

